Francesca Racca
Overview
Explore the profile of Francesca Racca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laserna-Mendieta E, Casabona-Frances S, Amorena E, Savarino E, Perez-Martinez I, Blas-Jhon L, et al.
United European Gastroenterol J
. 2024 Nov;
12(10):1388-1398.
PMID: 39513462
Background: Eosinophilic esophagitis (EoE) predominantly affects males across all ages; however, little is known about sex differences for other aspects of EoE. Objective: To investigate associations between sex and clinical...
2.
Migliorisi G, Mastrorocco E, Dal Buono A, Gabbiadini R, Pellegatta G, Spaggiari P, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064159
Background/objectives: Inflammatory bowel disease (IBD) and eosinophilic gastrointestinal diseases (EGIDs) are complex, multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. Their epidemiology, particularly for eosinophilic esophagitis (EoE), is increasing worldwide,...
3.
Navarro P, Feo-Ortega S, Casabona-Frances S, Gutierrez-Junquera C, Savarino E, Amorena E, et al.
Eur J Pediatr
. 2024 May;
183(8):3567-3578.
PMID: 38819501
This study compared short-term effectiveness of proton pump inhibitors (PPI), swallowed topical corticosteroids (STC), and dietary therapies in reversing clinical and histological features in pediatric patients with eosinophilic esophagitits (EoE)....
4.
Savarino E, Barbara G, Bilo M, De Bortoli N, Di Sabatino A, Oliva S, et al.
Therap Adv Gastroenterol
. 2024 May;
17:17562848241249570.
PMID: 38812705
Background: Eosinophilic esophagitis (EoE) is recognized as a chronic type 2 inflammatory disease characterized by the eosinophilic infiltration of the esophageal tissue, posing a significant disease burden and highlighting the...
5.
De Bortoli N, Visaggi P, Penagini R, Annibale B, Baiano Svizzero F, Barbara G, et al.
Dig Liver Dis
. 2024 Mar;
56(7):1173-1184.
PMID: 38521670
The present document constitutes Part 2 of the EoETALY Consensus Statements guideline on the diagnosis and management of eosinophilic esophagitis (EoE) developed by experts in the field of EoE across...
6.
De Bortoli N, Visaggi P, Penagini R, Annibale B, Baiano Svizzero F, Barbara G, et al.
Dig Liver Dis
. 2024 Feb;
56(6):951-963.
PMID: 38423918
Eosinophilic esophagitis (EoE) is a chronic type 2-mediated inflammatory disease of the esophagus that represents the most common eosinophilic gastrointestinal disease. Experts in the field of EoE across Italy (i.e.,...
7.
Laserna-Mendieta E, Navarro P, Casabona-Frances S, Savarino E, Amorena E, Perez-Martinez I, et al.
United European Gastroenterol J
. 2024 Jan;
12(5):585-595.
PMID: 38284792
Background: Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have occurred due to their active ingredients, formulations and doses. Objective: To assess...
8.
Ferri S, Montagna C, Casini M, Malvezzi L, Pirola F, Russo E, et al.
Ann Allergy Asthma Immunol
. 2023 Aug;
132(1):69-75.
PMID: 37652235
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with a substantial burden on patients' quality of life and impaired sleep quality. The most common CRSwNP endotype is characterized by...
9.
Ferreira R, Assis R, Racca F, Bontempi A, da Silva R, Wiench M, et al.
Genes (Basel)
. 2023 Aug;
14(8).
PMID: 37628700
Chromatin conformation, DNA methylation pattern, transcriptional profile, and non-coding RNAs (ncRNAs) interactions constitute an epigenetic pattern that influences the cellular phenotypic commitment and impacts the clinical outcomes in regenerative therapies....
10.
Nappi E, Racca F, Piona A, Messina M, Ferri S, Lamacchia D, et al.
Vaccines (Basel)
. 2023 May;
11(5).
PMID: 37243019
Concern has arisen about hypersensitivity reactions in patients with allergic reactions to drugs containing polyethylene glycol (PEG) or polysorbate 80 (PS80), excipients of currently available anti-SARS-CoV-2 mRNA vaccines. However, the...